LeisIMMUNE BOOST – 30 Tabs

Compare retailer offers

About this product

Scientific Background The outcome of the Canine leishmaniosis (CanL) by Leishmania infantum is linked to the immune response of the dog (Toepp and Petersen, 2020). From an immunological point of view, a predominant Th1 (cellular) immune response correlates with enhanced immunity and improved resistance to the disease (Toepp and Petersen, 2020). Conversely, disease progression has been associated with a predominance of the Th2 (humoral) immune response (Toepp and Petersen, 2020). Dogs able to control the disease typically exhibit a weak humoral immune response and a robust cellular immune response, characterized by low parasite burden. In contrast, clinically affected dogs demonstrate a prevalent Th2 immune response and a reduced Th1 response. In this context, intervention able to enhance the innate cellular immune response of the host appeared to offer a novel approach to addressing L. infantum infection control (Baxarias et al., 2019). How it works Boosts the cell-mediated immune response, enhancing protection against leishmaniosis. Effective in maintaining a stable clinical score and improving laboratory parameters: Leish titre, globulins, A/G, CRP and ferritin. Reduces the progr

More from Not specified